Understanding Immune Response to Chlamydia Infection
Part of Infections clinical trials.
This study examines how your body's immune system responds to a Chlamydia trachomatis infection by analyzing urine and blood samples. Researchers hope to better understand infection patterns and improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female
- You have tested positive for Chlamydia trachomatis (confirmed by a urine or vaginal swab test)
- You are not pregnant
- You have not taken antibiotics for Chlamydia (like doxycycline or azithromycin) in the past 14 days
- You are not currently in another clinical trial
- You do not have HIV
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new mRNA vaccine designed to prevent chlamydia infection. It is for adults aged 18 to 29 who have a higher risk of getting chlamydia.
This study compares two ways of testing for chlamydia and gonorrhea — the usual laboratory test versus a faster, point-of-care test done at the clinic. It looks at whether the faster test helps more people get the right treatment sooner.
This study looks at the parasite that causes trichomoniasis (a common sexually transmitted infection) to learn more about how it affects the body. By studying samples from people who have the infection, researchers hope to find better ways to diagnose or treat it.
This study evaluates a new rapid test for gonorrhea designed for women. You'll provide vaginal swab samples and complete a brief counseling session to help researchers understand how well the test works and whether patients can use it correctly.
This trial tests whether STI testing during pregnancy helps more women start and stay on PrEP (a daily pill that prevents HIV). If you join, you'll help find better ways to protect both mother and baby from HIV.
This study looks back at medical records of people who had pneumonia caused by Chlamydia pneumoniae, a type of bacteria. It aims to learn more about how this infection affects patients, which could help improve care in the future.
Hear when a new Chlamydia Trachomatis Genital Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.